
Opinion|Videos|January 19, 2024
Key Takeaways for Patients With Myelofibrosis
Author(s)Christine Cooper, RN, BSN, Aaron Gerds, MD, MS
Patients with myelofibrosis should reflect on their personal priorities and quality of life goals, understand the range of available JAK inhibitor treatment options, and openly communicate with their doctor to arrive at a shared decision for managing their disease.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CURE
1
Breast Cancer Treatments Awaiting FDA Decisions: 4 to Watch
2
FDA Approves Etcamah Plus CDK4/6 Inhibitor for ESR1-Mutated Breast Cancer
3
What Breast Cancer Survivors Should Know About Weight Loss and Long-Term Health
4
6 Cancer Drugs FDA Approved in August 2026 and What They Mean for You
5
